Search research articles
Contact Us
Filters
Showing results (191-200 of 373) with videos related to
Page
of 38
Sort By:
Oncology Letters
|
June 13, 2019
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study
Anjie Zhu, Peng Yuan, Jiayu Wang, et al.
Chinese Medical Journal
|
August 19, 2022
Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population
Hongnan Mo, Fei Ma, Qing Li, et al.
Therapeutic Advances in Medical Oncology
|
December 5, 2024
A non-inferiority, phase III trial of gemcitabine plus capecitabine <i>versus</i> gemcitabine plus carboplatin as first-line therapy and tumor-infiltrating lymphocytes as a prognostic biomarker in patients with advanced triple-negative breast cancer
Xiaodong Liu, Weipeng Zhao, Yongsheng Jia, et al.
Obesity Surgery
|
June 11, 2026
Correction: Early Serum Clusterin Reduction is Associated with Weight Loss and Type 2 Diabetes Remission after Bariatric Surgery
Yiming Si, Yinfang Tu, Yufei Wang, et al.
Talanta
|
June 6, 2020
Real-time and rapid quantification of microRNAs in cells and tissues using target-recycled enzyme-free amplification strategy
Wancun Zhang, Pin Zhang, Fei Zhang, et al.
Protein and Peptide Letters
|
December 9, 2024
Targeting APE1: Advancements in the Diagnosis and Treatment of Tumors
Minghui Hu, Yingyu Zhang, Pin Zhang, et al.
Clinical and Experimental Rheumatology
|
June 24, 2024
WNT16 as a promising biomarker for systemic lupus erythematosus and its role in regulating cell proliferation and apoptosis
Kefen Wang, Yiheng Jiang, Jianzhao Zhai, et al.
Cancer Biology & Medicine
|
May 5, 2023
Combined chemo-endocrine therapy as a potential new option for HR+/HER2- advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine
Xue Wang, Jian Yue, Yikun Kang, et al.
Thoracic Cancer
|
November 8, 2023
Efficacy of everolimus-based therapy in advanced triple-positive breast cancer: Experience from three cancer centers in China
Yujing Tan, Hanfang Jiang, Fei Ma, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 19, 2016
[Efficacy and safety of cisplatin plus capecitabine for patients with metastatic triple negative breast cancer progressing after anthracycline and taxane treatment]
Qiao Li, Binghe Xu, Qing Li, et al.
Page
of 38
Search research articles
Search
Showing results (191-200 of 373) with videos related to
Sort By:
Page
of 38
Oncology Letters
|
June 13, 2019
Apatinib combined with chemotherapy in patients with previously treated advanced breast cancer: An observational study
Anjie Zhu, Peng Yuan, Jiayu Wang, et al.
Chinese Medical Journal
|
August 19, 2022
Treatment patterns and clinical outcomes in patients with metastatic breast cancer treated with palbociclib-based therapies: real-world data in the Han population
Hongnan Mo, Fei Ma, Qing Li, et al.
Therapeutic Advances in Medical Oncology
|
December 5, 2024
A non-inferiority, phase III trial of gemcitabine plus capecitabine <i>versus</i> gemcitabine plus carboplatin as first-line therapy and tumor-infiltrating lymphocytes as a prognostic biomarker in patients with advanced triple-negative breast cancer
Xiaodong Liu, Weipeng Zhao, Yongsheng Jia, et al.
Obesity Surgery
|
June 11, 2026
Correction: Early Serum Clusterin Reduction is Associated with Weight Loss and Type 2 Diabetes Remission after Bariatric Surgery
Yiming Si, Yinfang Tu, Yufei Wang, et al.
Talanta
|
June 6, 2020
Real-time and rapid quantification of microRNAs in cells and tissues using target-recycled enzyme-free amplification strategy
Wancun Zhang, Pin Zhang, Fei Zhang, et al.
Protein and Peptide Letters
|
December 9, 2024
Targeting APE1: Advancements in the Diagnosis and Treatment of Tumors
Minghui Hu, Yingyu Zhang, Pin Zhang, et al.
Clinical and Experimental Rheumatology
|
June 24, 2024
WNT16 as a promising biomarker for systemic lupus erythematosus and its role in regulating cell proliferation and apoptosis
Kefen Wang, Yiheng Jiang, Jianzhao Zhai, et al.
Cancer Biology & Medicine
|
May 5, 2023
Combined chemo-endocrine therapy as a potential new option for HR+/HER2- advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine
Xue Wang, Jian Yue, Yikun Kang, et al.
Thoracic Cancer
|
November 8, 2023
Efficacy of everolimus-based therapy in advanced triple-positive breast cancer: Experience from three cancer centers in China
Yujing Tan, Hanfang Jiang, Fei Ma, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 19, 2016
[Efficacy and safety of cisplatin plus capecitabine for patients with metastatic triple negative breast cancer progressing after anthracycline and taxane treatment]
Qiao Li, Binghe Xu, Qing Li, et al.
Page
of 38